The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CCNE1 mRNA and cyclin E1 protein expression as predictive biomarkers for efficacy of palbociclib plus fulvestrant versus capecitabine in the phase III PEARL study.
 
Javier Pascual
No Relationships to Disclose
 
Miguel Gil-Gil
Honoraria - Kern Pharma; Pfizer
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo
Travel, Accommodations, Expenses - Kern Pharma; Novartis; Pfizer; Roche
 
Christoph Zielinski
Consulting or Advisory Role - Amgen; ARIAD; AstraZeneca; Athenex; Bristol-Myers Squibb; Fibrogen (Inst); Gilead Sciences; Imugene; Lilly; Merck KGaA; Merck Sharp & Dohme; Merrimack; Novartis; Pfizer; Roche; SERVIER; Shire (Inst); Tesaro
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
 
Margaret Hills
No Relationships to Disclose
 
Manuel Ruiz-Borrego
Consulting or Advisory Role - PFIZER
 
Eva M. Ciruelos
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Isaac Garcia-Murillas
No Relationships to Disclose
 
Montserrat Muñoz
Expert Testimony - Novartis; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Begoña Bermejo
Consulting or Advisory Role - MSD; Novartis; Roche
Speakers' Bureau - Eisai; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Claire Swift
No Relationships to Disclose
 
Mireia Margeli Vila
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Roche
 
Antonio Antón Torres
Consulting or Advisory Role - Bayer
Expert Testimony - Pfizer
 
Bella Nissenbaum
No Relationships to Disclose
 
Laura Murillo
No Relationships to Disclose
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jesus Herranz
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Angel Guerrero-Zotano
Consulting or Advisory Role - AstraZeneca; Novartis
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Repare Therapeutics; Roche; Taiho Pharmaceutical; Zeno pharmaceuticals
Research Funding - AstraZeneca (Inst); Bio-Rad (Inst); Clovis Oncology (Inst); Guardant Health (Inst); Pfizer (Inst); Roche (Inst)
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Other Relationship - Novartis; Roche